All lobbying filings

THE HARPLE GROUP, LLC

THE HARPLE GROUP, LLC filed a Q3 report for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION (PILMA) on October 14, 2026, reporting $30,000 in lobbying income.

Lobbying for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION (PILMA) · Trade Association

All filings by THE HARPLE GROUP, LLC · Everything PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION (PILMA) has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 14, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Prescription drug industry issues relating to domestic construction and maintenance, and prescription drug pricing Pharmacy Benefit Manager Transparency Act of 2023; Prescription Pricing for the People Act of 2023; HELP Copays Act; Delinking Revenue from Unfair Gouging Act (a/k/a The DRUG Act); Lowering Drug Costs for American Families Act; Protecting Patients Against PBM Abuses Act; The Drug Act; Lower Costs, More Transparency Act.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.